Jeff Jones's Stock Ratings

Oppenheimer Analyst

Jeff Jones is an analyst at Oppenheimer. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/26/2025

Overall Average Return

-22.1%

Smart Score

33.2%

Overall Average Return Percentile

11th

Number of Ratings

102
Buy NowGet Alert
03/26/2025ZURABuy Now
Zura Bio
$1.511158.28%
Jeff Jones33%
$20 → $19MaintainsOutperformGet Alert
03/26/2025CRVSBuy Now
Corvus Pharma
$3.49330.21%
Jeff Jones33%
$14 → $15MaintainsOutperformGet Alert
01/30/2025ALMSBuy Now
Alumis
$4.66586.7%
Jeff Jones33%
→ $32Initiates → OutperformGet Alert
01/24/2025EVHBuy Now
Evolent Health
$9.4590.48%
Jeff Jones33%
$28 → $18MaintainsOutperformGet Alert
12/11/2024CLRBBuy Now
Cellectar Biosciences
$0.36
Jeff Jones33%
DowngradeOutperform → PerformGet Alert
11/22/2024CATXBuy Now
Perspective Therapeutics
$2.24614.29%
Jeff Jones33%
$22 → $16MaintainsOutperformGet Alert
11/19/2024CLRBBuy Now
Cellectar Biosciences
$0.363204.87%
Jeff Jones33%
$14 → $12MaintainsOutperformGet Alert
11/18/2024EVHBuy Now
Evolent Health
$9.45196.3%
Jeff Jones33%
$34 → $28MaintainsOutperformGet Alert
11/18/2024YMABBuy Now
Y-mAbs Therapeutics
$4.84375.21%
Jeff Jones33%
→ $23Initiates → OutperformGet Alert
11/15/2024CMMBBuy Now
Chemomab Therapeutics
$1.15856.52%
Jeff Jones33%
$13 → $11ReiteratesOutperform → OutperformGet Alert
11/13/2024CRVSBuy Now
Corvus Pharma
$3.49301.53%
Jeff Jones33%
$8 → $14ReiteratesOutperform → OutperformGet Alert
11/08/2024VTYXBuy Now
Ventyx Biosciences
$1.23631.71%
Jeff Jones33%
$10 → $9ReiteratesOutperform → OutperformGet Alert
11/08/2024EVHBuy Now
Evolent Health
$9.45259.79%
Jeff Jones33%
$45 → $34MaintainsOutperformGet Alert
10/11/2024CLRBBuy Now
Cellectar Biosciences
$0.363755.69%
Jeff Jones33%
$14 → $14ReiteratesOutperform → OutperformGet Alert
10/11/2024CATXBuy Now
Perspective Therapeutics
$2.24882.14%
Jeff Jones33%
$22 → $22ReiteratesOutperform → OutperformGet Alert
09/27/2024KYMRBuy Now
Kymera Therapeutics
$30.3984.27%
Jeff Jones33%
$52 → $56MaintainsOutperformGet Alert
09/10/2024AVBPBuy Now
ArriVent BioPharma
$18.28113.35%
Jeff Jones33%
$35 → $39ReiteratesOutperform → OutperformGet Alert
08/15/2024AVBPBuy Now
ArriVent BioPharma
$18.2891.47%
Jeff Jones33%
$35 → $35ReiteratesOutperform → OutperformGet Alert
08/13/2024CATXBuy Now
Perspective Therapeutics
$2.24658.93%
Jeff Jones33%
$19 → $17MaintainsOutperformGet Alert
08/09/2024IMCRBuy Now
Immunocore Hldgs
$29.47202%
Jeff Jones33%
$87 → $89ReiteratesOutperform → OutperformGet Alert
08/08/2024PLRXBuy Now
Pliant Therapeutics
$1.482940.54%
Jeff Jones33%
$48 → $45MaintainsOutperformGet Alert
08/07/2024CRBPBuy Now
Corbus Pharmaceuticals
$5.921386.49%
Jeff Jones33%
$80 → $88MaintainsOutperformGet Alert
07/10/2024KYMRBuy Now
Kymera Therapeutics
$30.3971.11%
Jeff Jones33%
$52 → $52MaintainsOutperformGet Alert
07/10/2024CRBPBuy Now
Corbus Pharmaceuticals
$5.921251.35%
Jeff Jones33%
$80 → $80ReiteratesOutperform → OutperformGet Alert
06/18/2024CATXBuy Now
Perspective Therapeutics
$2.24
Jeff Jones33%
$2 → $19ReiteratesOutperform → OutperformGet Alert
06/07/2024MCRBBuy Now
Seres Therapeutics
$0.71
Jeff Jones33%
DowngradeOutperform → PerformGet Alert
06/06/2024VTYXBuy Now
Ventyx Biosciences
$1.23713.01%
Jeff Jones33%
$12 → $10MaintainsOutperformGet Alert
06/03/2024CRBPBuy Now
Corbus Pharmaceuticals
$5.921251.35%
Jeff Jones33%
$60 → $80MaintainsOutperformGet Alert
05/10/2024ZURABuy Now
Zura Bio
$1.511290.73%
Jeff Jones33%
$16 → $21MaintainsOutperformGet Alert
05/09/2024MCRBBuy Now
Seres Therapeutics
$0.71462.83%
Jeff Jones33%
$5 → $4MaintainsOutperformGet Alert
05/08/2024CRBPBuy Now
Corbus Pharmaceuticals
$5.92913.51%
Jeff Jones33%
$58 → $60MaintainsOutperformGet Alert
05/07/2024PLRXBuy Now
Pliant Therapeutics
$1.483143.24%
Jeff Jones33%
$47 → $48ReiteratesOutperform → OutperformGet Alert
05/07/2024CRVSBuy Now
Corvus Pharma
$3.49129.44%
Jeff Jones33%
$7 → $8MaintainsOutperformGet Alert
05/06/2024CMMBBuy Now
Chemomab Therapeutics
$1.15421.74%
Jeff Jones33%
→ $6UpgradePerform → OutperformGet Alert
05/03/2024KYMRBuy Now
Kymera Therapeutics
$30.3971.11%
Jeff Jones33%
$53 → $52MaintainsOutperformGet Alert
04/22/2024KYMRBuy Now
Kymera Therapeutics
$30.3974.4%
Jeff Jones33%
→ $53Initiates → OutperformGet Alert
04/01/2024ZURABuy Now
Zura Bio
$1.51959.6%
Jeff Jones33%
$17 → $16ReiteratesOutperform → OutperformGet Alert
04/01/2024CATXBuy Now
Perspective Therapeutics
$2.24-33.04%
Jeff Jones33%
$12 → $15ReiteratesOutperform → OutperformGet Alert
04/01/2024ANTXBuy Now
AN2 Therapeutics
$1.52
Jeff Jones33%
ReiteratesPerform → PerformGet Alert
03/28/2024CLRBBuy Now
Cellectar Biosciences
$0.363204.87%
Jeff Jones33%
$11 → $12ReiteratesOutperform → OutperformGet Alert
03/20/2024CRVSBuy Now
Corvus Pharma
$3.49100.76%
Jeff Jones33%
$8 → $7MaintainsOutperformGet Alert
03/19/2024CATXBuy Now
Perspective Therapeutics
$2.24-46.43%
Jeff Jones33%
$12 → $12ReiteratesOutperform → OutperformGet Alert
03/13/2024CRBPBuy Now
Corbus Pharmaceuticals
$5.92879.73%
Jeff Jones33%
$51 → $58ReiteratesOutperform → OutperformGet Alert
03/12/2024VTYXBuy Now
Ventyx Biosciences
$1.23875.61%
Jeff Jones33%
→ $12UpgradePerform → OutperformGet Alert
03/08/2024CMMBBuy Now
Chemomab Therapeutics
$1.15
Jeff Jones33%
MaintainsPerformGet Alert
03/06/2024MCRBBuy Now
Seres Therapeutics
$0.71603.53%
Jeff Jones33%
$9 → $5MaintainsOutperformGet Alert
03/01/2024EVHBuy Now
Evolent Health
$9.45376.19%
Jeff Jones33%
→ $45Initiates → OutperformGet Alert
02/29/2024PDCOBuy Now
Patterson Cos
$31.24-3.97%
Jeff Jones33%
$32 → $30MaintainsNeutralGet Alert
02/21/2024VTYXBuy Now
Ventyx Biosciences
$1.23
Jeff Jones33%
Reiterates → PerformGet Alert
02/12/2024ANTXBuy Now
AN2 Therapeutics
$1.52
Jeff Jones33%
DowngradeOutperform → PerformGet Alert
01/29/2024CRBPBuy Now
Corbus Pharmaceuticals
$5.92761.49%
Jeff Jones33%
$20 → $51MaintainsOutperformGet Alert
01/16/2024MCRBBuy Now
Seres Therapeutics
$0.711166.36%
Jeff Jones33%
$10 → $9MaintainsOutperformGet Alert
01/05/2024FUSNBuy Now
Fusion Pharmaceuticals
Jeff Jones33%
$13 → $15MaintainsOutperformGet Alert
12/27/2023FUSNBuy Now
Fusion Pharmaceuticals
Jeff Jones33%
$13 → $13ReiteratesOutperform → OutperformGet Alert
11/30/2023PDCOBuy Now
Patterson Cos
$31.242.43%
Jeff Jones33%
$35 → $32MaintainsNeutralGet Alert
09/29/2023FUSNBuy Now
Fusion Pharmaceuticals
Jeff Jones33%
→ $13Initiates → OutperformGet Alert
08/10/2023PLRXBuy Now
Pliant Therapeutics
$1.483413.51%
Jeff Jones33%
$51 → $52MaintainsOutperformGet Alert
08/09/2023CRBPBuy Now
Corbus Pharmaceuticals
$5.92271.62%
Jeff Jones33%
→ $22ReiteratesOutperform → OutperformGet Alert
07/05/2023VTYXBuy Now
Ventyx Biosciences
$1.234940.65%
Jeff Jones33%
$62 → $62ReiteratesOutperform → OutperformGet Alert
06/22/2023PDCOBuy Now
Patterson Cos
$31.2412.04%
Jeff Jones33%
$31 → $35MaintainsNeutralGet Alert
06/07/2023CMMBBuy Now
Chemomab Therapeutics
$1.15
Jeff Jones33%
DowngradeOutperform → PerformGet Alert
06/01/2023NOVNBuy Now
Novan
Jeff Jones33%
DowngradeOutperform → PerformGet Alert
05/25/2023CYCCBuy Now
Cyclacel Pharmaceuticals
$0.312489.83%
Jeff Jones33%
→ $120MaintainsOutperformGet Alert
05/23/2023RAINBuy Now
Rain Oncology
$1.95
Jeff Jones33%
DowngradeOutperform → PerformGet Alert
05/19/2023CATXBuy Now
Perspective Therapeutics
$2.24-46.43%
Jeff Jones33%
$10 → $12MaintainsOutperformGet Alert
05/16/2023PNTBuy Now
POINT Biopharma Global
Jeff Jones33%
→ $13ReiteratesOutperform → OutperformGet Alert
05/16/2023NOVNBuy Now
Novan
Jeff Jones33%
$9 → $8MaintainsOutperformGet Alert
05/11/2023PMVPBuy Now
PMV Pharma
$1.161193.1%
Jeff Jones33%
→ $15ReiteratesOutperform → OutperformGet Alert
05/10/2023PLRXBuy Now
Pliant Therapeutics
$1.483345.95%
Jeff Jones33%
$44 → $51MaintainsOutperformGet Alert
05/10/2023CRBPBuy Now
Corbus Pharmaceuticals
$5.92271.62%
Jeff Jones33%
→ $22UpgradePerform → OutperformGet Alert
04/18/2023CMMBBuy Now
Chemomab Therapeutics
$1.15508.7%
Jeff Jones33%
$12 → $7MaintainsOutperformGet Alert
03/30/2023ANTXBuy Now
AN2 Therapeutics
$1.521478.95%
Jeff Jones33%
$20 → $24MaintainsOutperformGet Alert
03/24/2023MBRXBuy Now
Moleculin Biotech
$1.06371.65%
Jeff Jones33%
→ $75Reiterates → OutperformGet Alert
03/24/2023VTYXBuy Now
Ventyx Biosciences
$1.234940.65%
Jeff Jones33%
$65 → $62MaintainsOutperformGet Alert
03/10/2023PLRXBuy Now
Pliant Therapeutics
$1.482872.97%
Jeff Jones33%
$43 → $44MaintainsOutperformGet Alert
03/07/2023CYCCBuy Now
Cyclacel Pharmaceuticals
$0.312489.83%
Jeff Jones33%
$150 → $120MaintainsOutperformGet Alert
03/02/2023PMVPBuy Now
PMV Pharma
$1.161193.1%
Jeff Jones33%
$28 → $15MaintainsOutperformGet Alert
03/01/2023RXDXBuy Now
Prometheus Biosciences
Jeff Jones33%
$125 → $150MaintainsOutperformGet Alert
01/27/2023VTYXBuy Now
Ventyx Biosciences
$1.234778.05%
Jeff Jones33%
$55 → $60MaintainsOutperformGet Alert
12/08/2022RXDXBuy Now
Prometheus Biosciences
Jeff Jones33%
$61 → $125MaintainsOutperformGet Alert
11/17/2022EVAXBuy Now
Evaxion Biotech
$1.70547.06%
Jeff Jones33%
$1600 → $1100MaintainsOutperformGet Alert
10/11/2022PNTBuy Now
POINT Biopharma Global
Jeff Jones33%
→ $20Initiates → OutperformGet Alert
10/04/2022RXDXBuy Now
Prometheus Biosciences
Jeff Jones33%
$50 → $65MaintainsOutperformGet Alert
09/12/2022VTYXBuy Now
Ventyx Biosciences
$1.235184.55%
Jeff Jones33%
$40 → $65MaintainsOutperformGet Alert
08/16/2022VTYXBuy Now
Ventyx Biosciences
$1.233152.03%
Jeff Jones33%
$30 → $40MaintainsOutperformGet Alert
07/19/2022NOVNBuy Now
Novan
Jeff Jones33%
→ $12Initiates → OutperformGet Alert
07/18/2022CLRBBuy Now
Cellectar Biosciences
$0.361414.73%
Jeff Jones33%
→ $55Assumes → OutperformGet Alert
07/18/2022CYCCBuy Now
Cyclacel Pharmaceuticals
$0.315403.4%
Jeff Jones33%
→ $255Assumes → OutperformGet Alert
07/18/2022EVAXBuy Now
Evaxion Biotech
$1.70841.18%
Jeff Jones33%
→ $1600Assumes → OutperformGet Alert
07/18/2022MBRXBuy Now
Moleculin Biotech
$1.061220.63%
Jeff Jones33%
$30 → $210Assumes → OutperformGet Alert
07/18/2022VBLTBuy Now
Vascular Biogenics
Jeff Jones33%
→ $192.5Assumes → OutperformGet Alert
06/09/2022PMVPBuy Now
PMV Pharma
$1.162744.83%
Jeff Jones33%
$30 → $33MaintainsOutperformGet Alert
04/01/2022RAINBuy Now
Rain Oncology
$1.95669.23%
Jeff Jones33%
→ $15Initiates → OutperformGet Alert
03/10/2022CMMBBuy Now
Chemomab Therapeutics
$1.151639.13%
Jeff Jones33%
$30 → $20MaintainsOutperformGet Alert
03/02/2022PMVPBuy Now
PMV Pharma
$1.16
Jeff Jones33%
UpgradePerform → OutperformGet Alert
02/01/2022VTYXBuy Now
Ventyx Biosciences
$1.232339.02%
Jeff Jones33%
→ $30Initiates → OutperformGet Alert
12/10/2021PLRXBuy Now
Pliant Therapeutics
$1.482602.7%
Jeff Jones33%
→ $40Initiates → OutperformGet Alert
12/08/2021RXDXBuy Now
Prometheus Biosciences
Jeff Jones33%
$35 → $50UpgradePerform → OutperformGet Alert
11/15/2021RXDXBuy Now
Prometheus Biosciences
Jeff Jones33%
DowngradeOutperform → PerformGet Alert
10/05/2021RXDXBuy Now
Prometheus Biosciences
Jeff Jones33%
→ $35Initiates → OutperformGet Alert
08/19/2021PMVPBuy Now
PMV Pharma
$1.16
Jeff Jones33%
Initiates → PerformGet Alert
05/07/2021CMMBBuy Now
Chemomab Therapeutics
$1.153552.17%
Jeff Jones33%
→ $42Initiates → OutperformGet Alert

Recent Analyst Stock Rating News

The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free